TETI, Giuseppe
 Distribuzione geografica
Continente #
EU - Europa 12.171
NA - Nord America 9.791
AS - Asia 5.684
SA - Sud America 1.902
AF - Africa 160
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 8
Totale 29.729
Nazione #
US - Stati Uniti d'America 9.630
RU - Federazione Russa 6.093
SG - Singapore 2.297
CN - Cina 1.952
BR - Brasile 1.675
IE - Irlanda 1.414
SE - Svezia 1.256
IT - Italia 674
DE - Germania 661
UA - Ucraina 553
HK - Hong Kong 552
FR - Francia 464
FI - Finlandia 324
VN - Vietnam 271
GB - Regno Unito 256
PL - Polonia 220
IN - India 130
AR - Argentina 84
BD - Bangladesh 80
CA - Canada 62
IQ - Iraq 54
CZ - Repubblica Ceca 52
MX - Messico 51
TR - Turchia 50
BE - Belgio 49
ZA - Sudafrica 46
EC - Ecuador 37
MA - Marocco 36
PK - Pakistan 36
JP - Giappone 31
UZ - Uzbekistan 31
CO - Colombia 29
ES - Italia 28
NL - Olanda 26
AT - Austria 23
VE - Venezuela 23
ID - Indonesia 22
KE - Kenya 19
CL - Cile 18
AE - Emirati Arabi Uniti 17
SA - Arabia Saudita 17
TN - Tunisia 17
PH - Filippine 16
JO - Giordania 14
AZ - Azerbaigian 12
EG - Egitto 12
UY - Uruguay 12
DO - Repubblica Dominicana 11
DZ - Algeria 11
BG - Bulgaria 9
IR - Iran 9
LT - Lituania 9
NP - Nepal 9
PY - Paraguay 9
IL - Israele 8
KG - Kirghizistan 8
KZ - Kazakistan 8
PE - Perù 8
PS - Palestinian Territory 8
AL - Albania 7
AU - Australia 7
CR - Costa Rica 7
JM - Giamaica 7
MY - Malesia 7
PT - Portogallo 7
RO - Romania 7
CH - Svizzera 6
EU - Europa 6
LV - Lettonia 6
OM - Oman 6
PA - Panama 6
AM - Armenia 5
HN - Honduras 5
SN - Senegal 5
AO - Angola 4
BN - Brunei Darussalam 4
BO - Bolivia 4
GT - Guatemala 4
LB - Libano 4
NZ - Nuova Zelanda 4
BH - Bahrain 3
CI - Costa d'Avorio 3
DK - Danimarca 3
GR - Grecia 3
GY - Guiana 3
HR - Croazia 3
KH - Cambogia 3
NO - Norvegia 3
TW - Taiwan 3
AG - Antigua e Barbuda 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CY - Cipro 2
EE - Estonia 2
GE - Georgia 2
HU - Ungheria 2
KR - Corea 2
LK - Sri Lanka 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
Totale 29.700
Città #
Moscow 1.856
Dublin 1.412
Singapore 1.254
Dallas 1.217
Ashburn 1.147
Chandler 1.128
Jacksonville 1.121
Nyköping 687
Hong Kong 550
Beijing 532
Shenzhen 469
San Jose 350
Messina 288
The Dalles 282
Dearborn 249
Princeton 243
Los Angeles 242
Cambridge 235
Medford 235
Lauterbourg 221
Warsaw 214
Boardman 213
Des Moines 196
Ann Arbor 188
Buffalo 141
New York 117
Munich 115
São Paulo 115
Ho Chi Minh City 82
Woodbridge 80
Bremen 70
Tianjin 69
Hanoi 61
Shenyang 60
Wilmington 57
Jinan 55
Orem 53
Belo Horizonte 50
Brussels 48
San Mateo 47
Brno 46
Guangzhou 45
Helsinki 43
Chennai 41
Council Bluffs 41
Redondo Beach 39
Turku 39
Frankfurt am Main 35
Rio de Janeiro 35
Nanjing 34
Santa Clara 33
Pune 32
Brasília 30
Lancaster 30
Milan 30
Nuremberg 30
Haikou 29
Tashkent 29
Tokyo 29
Hebei 26
Rome 26
Ningbo 25
Seattle 25
Shanghai 25
Houston 24
Johannesburg 24
Zhengzhou 24
Brooklyn 23
Dong Ket 23
Baghdad 22
Norwalk 22
Curitiba 21
Düsseldorf 21
Stockholm 21
Dhaka 20
London 20
Montreal 20
Porto Alegre 20
Mumbai 19
Amsterdam 18
Taiyuan 18
Denver 17
Goiânia 17
Poplar 17
Ribeirão Preto 17
Campinas 16
Hangzhou 16
Taizhou 16
Guayaquil 15
Nairobi 14
Phoenix 14
Vienna 14
Washington 14
Amman 13
Boston 13
Catania 13
Chicago 13
Guarulhos 13
Haiphong 13
Mexico City 13
Totale 17.184
Nome #
Immunogenic Properties of Streptococcus agalactiae FbsA Fragments. 616
ATTIVAZIONE DI NLRP3 IMFLAMMASOMA NEL CORSO DELLE INFEZIONI SOSTENUTE DAGLI STREPTOCOCCHI DI GRUPPO B 274
Functional characterization of a monoclonal antibody epitope using a lambda phage display-deep sequencing platform 241
Neutrophils Directly Recognize Group B Streptococci and Contribute to Interleukin-1β Production during Infection. 236
Antiidiotypic DNA vaccination induces serum bactericidal activity and protection against group B meningococci 230
Analysis of the secretome of the group B Streptococcus 216
Epitope mapping of a monoclonal antibody directed against neisserial heparin binding antigen using next generation sequencing of antigen-specific libraries 214
Phage display revisited: Epitope mapping of a monoclonal antibody directed against Neisseria meningitidis adhesin A using the PROFILER technology 213
The plasminogen binding protein PbsP is required for brain invasion by hypervirulent CC17 Group B streptococci 209
A new surface protein of Streptococcus suis identified by proteomics 203
Anti-idiotypic B5 single chain variable fragment [synthetic construct]. 201
A surface protein of Streptococcus suis serotype 2 identified by proteomics protects mice against infection 200
Analysis of the Streptococcus agalactiae exoproteome. 200
Anti-idiotypic G1 single chain variable fragment [synthetic construct]. 195
Antibody killing of Candida albicans after immunization with peptides mimicking a killer toxin receptor 193
Activation of the NLRP3 inflammasome by group B streptococci. 190
CXCL1/2 chemokines are newly synthesized by neutrophils and released at high levels after recognition of live Group B Streptococcus by means of endosomal Toll-like receptors 190
Approccio proteomico per l’analisi comparativa del secretoma di coltura di S. agalactiae, ceppo Nem316 189
Immunoprotective activities of a Streptococcus suis pilus subunit in murine models of infection. 185
Caratterizzazione molecolare di glicoproteine criptococciche capaci di indurre risposte umorali. 184
Anti-idiotypic vaccination against group B streptococci 183
Characterization of two novel Cryptococcal mannoproteins recognized by immune sera 182
Bacteroides fragilis-derived lipopolysaccharide produces cell activation and lethal toxicity via toll-like receptor 4 178
Neutrophils Enhance Their Own Influx to Sites of Bacterial Infection via Endosomal TLR-Dependent Cxcl2 Production 178
beta(2) integrins are involved in cytokine responses to whole Gram-positive bacteria 177
The Streptococcus agalactiae cell wall-anchored protein PbsP mediates adhesion to and invasion of epithelial cells by exploiting the host vitronectin/αvintegrin axis 173
Bacteroides fragilis lipopolysaccharide activates cells via CD14/MD2/TLR4 171
“Antibody killing of Candida albicans after immunization with peptides mimicking a killer toxin receptor” 171
NEUTROPHILS PRODUCE HIGH LEVELS OF CHEMOKINES (CXCL1/2) AFTER SENSING GROUP B STREPTOCOCCUS THROUGH ENDOSOMAL TLRS 171
Age-related sensitivity of neonatal mice to toxicity induced by heat-killed group B streptococci. 169
Essential role of interleukin-1 signaling in host defenses against group B streptococcus 169
Immunoprotective activities of a Streptococcus suis pilus subunit in murine models of infection 168
Protective Activity of Streptococcus pneumoniae Spr1875 Protein Fragments Identified Using a Phage Displayed Genomic Library. 168
Neonatal mouse immunity against group B streptococcal infection by maternal vaccination with recombinant anti-idiotypes 167
Attivazione dell'inflammasoma da parte di S.pneumoniae 167
Peptide mimics of the group B meningococcal capsule induce bactericidal and protective antibodies after immunization 166
Costruzione e screening di librerie “lambda display” da genoma completo di streptococchi patogeni per l’identificazione di prodotti genici che interagiscono con i tessuti dell’ospite. 166
Plasminogen- and Fibronectin–Binding Protein B Is Involved in the Adherence of Streptococcus pneumoniae to Human Epithelial Cells. 165
The IL-1b/CXCL1/2/neutrophil axis mediates host protection against group B streptococcal infection 164
Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells 164
NEUTROPHILS ARE MAINLY RESPONSIBLE FOR IL-1Β PRODUCTION DURING GROUP B STREPTOCOCCUS INFECTION 163
PbsP, a cell wall-anchored protein that binds plasminogen to promote hematogenous dissemination of Group B Streptococcus 163
CELL ACTIVATION INDUCED BY LIPOTEICHOIC ACID AND POLYSACCHARAIDES FRM STREPTOCOCCI. 162
MyD88 and TLR2, but not TLR4, are required for host defense against Cryptococcus neoformans 162
Protective activity of a protein fragment identified by the screening of a Streptococcus pneumoniae phage-displayed genomic library 162
Identificazione mediante “Phage Display” diframmenti biologicamente attivi della fibrinogenbinding protein A (FbsA) di Streptococcus agalactiae. 161
Dual role of TLR2 and myeloid differentiation factor 88 in a mouse model of invasive group B streptococcal disease 160
A meeting of mimics. 160
Role of gamma interferon in a neonatal mouse model of group B streptococcal disease 160
Isolation of bacterial RNA from infected host tissues: application for transcriptomic studies of group B streptococci 160
Neutrophils discriminate live from dead bacteria by integrating signals initiated by Fprs and TLRs 159
Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria 158
Rapid Profiling of the Antigen Regions Recognized by Serum Antibodies Using Massively Parallel Sequencing of Antigen- Specific Libraries 157
AGE-RELATED MORTALITY AND ADHERENT SPLENIC CELL MEDIATOR PRODUCTION TO ENDOTOXIN IN THE RAT 156
Immunogenic mimics of Brucella lipopolysaccharide epitopes 155
Yeast Killer Toxin-Like Candidacidal Ab6 Antibodies Elicited through the Manipulation of the Idiotypic Cascade 155
La proteina FbsA di Streptococcus agalactiae è unimportante fattore di virulenza 154
Neonatal hypersusceptibility to endotoxin correlates with increased tumor necrosis factor production in mice 153
Ruolo dell'interluchina 18 nelle infezioni da streptococco di gruppo B. 152
Adherence of group B streptococci to adult and neonatal epithelial cells mediated by lipoteichoic acid. 152
ANTI-LIPOTEICHOIC ACID ANTIBODIES ENHANCE RELEASE OF CYTOKINES BY MONOCYTES SENSITIZED WITH LIPOTEICHOIC ACID 151
Plasminogen- and fibronectin-binding protein B is involved in the adherence of Streptococcus pneumoniae to human epithelial cells 151
Evaluation of a rapid method to exclude the presence of certain enteric pathogens in stool specimens. 151
Proceedings of the second Centro 3R Annual Meeting | September 30th - October 1st of Biomedical Science and Engineering. Vol. 4 No. s1 (2021) 151
Interleukin-6 production by human monocytes stimulated with Cryptococcus neoformans components 149
Effects of taxol on TNF-alpha and IL-6 production by human peripheral blood cells. 148
The Phagocyte, Metchnikoff, and the Foundation of Immunology 146
Uso del “phage display”per caratterizzare ilrepertorio anticorpale indotto da vaccinazione. 144
Role of TLR13 in innate immune recognition of group B streptococci 144
Virus ed infezioni alimentari: il caso dell’epatite A 143
Combating antibiotic resistance in S. pneumoniae infections: identification of pneumolysin binding peptides 142
BETA-LACTAM ANTIBIOTICS (AZTREONAM, AMPICILLIN, CEFAZOLIN AND CEFTAZIDIME) IN THE CONTROL AND ERADICATION OF SALMONELLA- TYPHIMURIUM IN NATURALLY RESISTANT AND SUSCEPTIBLE MICE 142
Immunoprotective activity of a Streptococcus pneumoniae protein identified by phage display. 142
Recognition of Neisseria meningitidis by the Long Pentraxin PTX3 and Its Role as an Endogenous Adjuvant 141
Effects of anti-cytokine treatments in neonatal sepsis models 141
Role of host's immune response in infections caused by Streptococcus pneumoniae 141
[Genetic techniques for the production of influenza vaccines (author's transl)]. 140
VACCINE FORMULATIONS COMPRISING ANTIIDIOTYPIC ANTIBODIES WHICH IMMUNOLOGICALLY MIMIC GROUP B STREPTOCOCCAL CARBOHYDRATES 139
Prevention of endotoxin-induced lethality in neonatal mice by interleukin-13 139
Identification and cloning of a cryptococcal deacetylase that produces protective immune responses 138
Cross reattività di una lipoproteina di Neisseriameningitidis con la proteina legante il fattore H (fHbp) 137
Plasminogen binding and immunoprotective properties of the Mk-rich domain of PbsP, a cell wall protein from Streptococcus agalactiae 137
BENEFICIAL-EFFECTS OF INTERLEUKIN-6 IN NEONATAL MOUSE MODELS OF GROUP-B STREPTOCOCCAL DISEASE 135
[Echocardiographic size of the left atrium and pulmonary "capillary" pressure in different cardiopathies]. 135
Interleukin-18 is an essential element in host resistance to experimental group B streptococcal disease in neonates 134
Compositional analysis of the major capsular polysaccharides of Cryptococcus neoformans by high-performance anion-exchange chromatography with pulsed amperometric detection (HPAEC-PAD) 133
Induction of bactericidal antibodies by DNA Immunization with peptide mimics of the meningococcal capsule 133
Selection of Neisseria meningitidis group B antigenic epitopes using lambda libraries. 133
Plasminogen- and fibronectin–binding protein B is involved in the adherence of Streptococcus pneumoniae to human epithelial cell 132
Identification of fibrinogen binding protein fragments using genomic phage display libraries of Group B Streptococcus 132
The dual role of innate immunity during influenza 132
Immunità protettiva indotta da una glutamina sintetasi di Cryptococcus neoformans 131
Vaccinazione anti-idiotipica a DNA per l'induzione di anticorpi diretti contro il polissacaride di batteri capsulati. 131
Pro-interleukin-1 beta processing in response to streptococci is totally caspase-1 dependent in vitro, but not in vivo. 131
Comparison of six systems for the identification of Enterobacteriaceae. 129
Caratterizzazione immunologica di nuovi antigeni proteici di Streptococcus pneumoniae selezionati mediante “phage-display 129
[Refractory junctional tachycardia controlled by radio-frequency programmed stimulation in association with amiodarone treatment]. 128
Interleukin-10 protects neonatal mice from lethal group B streptococcal infection 125
[Pseudoischemic unstable T wave with familial incidence]. 125
[Comparative study of antistreptolysin O, anti-streptokinase and anti-streptozyme antibodies and antibodies against polysaccharides of group A Streptococcus]. 124
Totale 16.669
Categoria #
all - tutte 91.491
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.491


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021429 0 0 0 0 0 0 0 0 0 199 139 91
2021/20221.600 18 259 16 34 37 11 114 76 17 192 288 538
2022/20234.266 341 348 178 388 412 408 58 243 1.712 19 115 44
2023/20241.456 86 159 526 86 105 212 7 58 2 33 16 166
2024/20254.594 79 53 81 289 140 161 89 1.123 1.191 258 367 763
2025/202612.910 550 885 1.098 717 1.070 3.202 1.622 1.646 1.709 411 0 0
Totale 29.910